Cargando…

Tumor necrosis factor receptor‐associated factor 6 contributes to malignant behavior of human cancers through promoting AKT ubiquitination and phosphorylation

Tumor necrosis factor receptor‐associated factor 6 (TRAF6) has been found to be involved in carcinogenesis in multiple cancers. However, the precise role of TRAF6 in cancer has not been extensively investigated and remains largely unknown. In this study, we aimed to investigate the biological functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jianbo, Liu, Zengying, Xu, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549921/ https://www.ncbi.nlm.nih.gov/pubmed/30945383 http://dx.doi.org/10.1111/cas.14012

Ejemplares similares

Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Associates with Huntingtin Protein and Promotes Its Atypical Ubiquitination to Enhance Aggregate Formation
por: Zucchelli, Silvia, et al.
Publicado: (2011)

CTRP6(C1q/Tumor Necrosis Factor (TNF)-related protein-6) alleviated the sevoflurane induced injury of mice central nervous system by promoting the expression of p-Akt (phosphorylated Akt)
por: Liu, Zhiwen, et al.
Publicado: (2021)

Phosphorylation and activation of ubiquitin-specific protease-14 by Akt regulates the ubiquitin-proteasome system
por: Xu, Daichao, et al.
Publicado: (2015)

Cytoplasmic Tail Phosphorylation of the α-Factor Receptor Is Required for Its Ubiquitination and Internalization
por: Hicke, Linda, et al.
Publicado: (1998)

Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway
por: Zhao, Zechen, et al.
Publicado: (2021)

Kinetic Constraints in the Specific Interaction between Phosphorylated Ubiquitin and Proteasomal Shuttle Factors
por: Qin, Ling-Yun, et al.
Publicado: (2021)

CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation
por: Wang, Junpu, et al.
Publicado: (2023)

Phosphorylated ubiquitin chain is the genuine Parkin receptor
por: Okatsu, Kei, et al.
Publicado: (2015)

Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer
por: Wang, Linlin, et al.
Publicado: (2017)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
por: Li, Lei, et al.
Publicado: (2019)

Ubiquitination of the yeast a-factor receptor
Publicado: (1996)

Role of tumor necrosis factor receptor-associated factor 6 in pyroptosis during acute pancreatitis
por: Wei, Biwei, et al.
Publicado: (2021)

UBE2T promotes glioblastoma malignancy through ubiquitination‐mediated degradation of RPL6
por: Tao, Xuxiu, et al.
Publicado: (2022)

Epidermal growth factor–stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis
por: Garay, Camilo, et al.
Publicado: (2015)

Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor
Publicado: (1993)

Requirement of Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 in Interleukin 17 Signal Transduction
por: Schwandner, Ralf, et al.
Publicado: (2000)

Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis
por: Zhu, Lang-Jing, et al.
Publicado: (2012)

Expression and Clinical Significance of Tumor Necrosis Factor Receptor-Associated Factor 6 in Patients With Colon Cancer
por: Zhang, Tao, et al.
Publicado: (2016)

Expression, Localization, and Phosphorylation of Akt1 in Benign and Malignant Thyroid Lesions
por: Krześlak, Anna, et al.
Publicado: (2011)

Metformin promotes cGAS/STING signaling pathway activation by blocking AKT phosphorylation in gastric cancer
por: Shen, Qian, et al.
Publicado: (2023)

miR-382-3p downregulation contributes to the carcinogenesis of lung adenocarcinoma by promoting AKT SUMOylation and phosphorylation
por: Fang, Hua, et al.
Publicado: (2022)

Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans
por: Stachon, Peter, et al.
Publicado: (2010)

Pathogenic Functions of Tumor Necrosis Factor Receptor-Associated Factor 6 Signaling Following Traumatic Brain Injury
por: Huang, Huan, et al.
Publicado: (2021)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Decrotonylation of AKT1 promotes AKT1 phosphorylation and activation during myogenic differentiation
por: Qian, Zhengyu, et al.
Publicado: (2022)

Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer
por: Qi, Yuanlin, et al.
Publicado: (2020)

Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif‐containing 37‐induced tumor necrosis factor receptor‐associated factor 2 ubiquitination
por: Zheng, Ya, et al.
Publicado: (2022)

JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis
por: Huntwork-Rodriguez, Sarah, et al.
Publicado: (2013)

Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9
por: Zhang, Bao-gui, et al.
Publicado: (2014)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancy
por: Phan, Hiep, et al.
Publicado: (2020)

Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?
por: Oh, Gyu Man, et al.
Publicado: (2020)

AB044. AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation
por: Bao, Jiming, et al.
Publicado: (2016)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
por: Sheng, Yuqiao, et al.
Publicado: (2018)

Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells
por: Wittenberg, Avigail Dreazen, et al.
Publicado: (2016)

Protein Levels of Several Arabidopsis Auxin Response Factors Are Regulated by Multiple Factors and ABA Promotes ARF6 Protein Ubiquitination
por: Li, Keke, et al.
Publicado: (2020)

Tumor Necrosis Factor Receptor 2: Its Contribution to Acute Cellular Rejection and Clear Cell Renal Carcinoma
por: Wang, Jun, et al.
Publicado: (2013)

Bid Promotes K63-Linked Polyubiquitination of Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) and Sensitizes to Mutant SOD1-Induced Proinflammatory Signaling in Microglia123
por: Kinsella, Sinéad, et al.
Publicado: (2016)

Tumor necrosis factor receptor-mediated signaling pathways
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_j12ccaklo8h8qlvh8suk5p3d1g